Loading...
Loading...
Among the 5 tracked institutional investors we monitor, VYNE (VYNE THERAPEUTICS INC) is held with a combined value of $536.11K across 906,458 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $307.38K (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 1 fund increased its holdings.
Total Institutional Value
$536.11K
Total Shares Held
906,458
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $307.38K | 0.00% | +1585.3% |
| 2 | VANGUARD GROUP INC | $182.44K | 0.00% | New |
| 3 | BlackRock, Inc. | $26.53K | 0.00% | - |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $10.34K | 0.00% | New |
| 5 | STATE STREET CORP | $9.42K | 0.00% | - |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of VYNE with a position worth $307.38K, representing 0.00% of their portfolio. In total, 5 institutional investors hold VYNE with a combined value of $536.11K.
In the most recent quarter, 2 funds opened a new position in VYNE. Additionally, 1 increased their holdings.
Institutional investors hold $536.11K worth of VYNE stock across 5 positions. The largest institutional holder is CITADEL ADVISORS LLC with $307.38K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For VYNE, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their VYNE positions.